PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
about
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsInteractions between Myc and Mediators of Inflammation in Chronic Liver DiseasesCancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysisChemotherapy and chemoprevention by thiazolidinedionesEupolyphaga sinensis walker displays inhibition on hepatocellular carcinoma through regulating cell growth and metastasis signaling.MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cellsDownregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transitionc-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells.Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cellsEmerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinomaMicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transitionPeroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile.Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.Diabetes and cancer relationships.Hepatitis D and hepatocellular carcinoma.The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan.Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.Molecular Signatures of Recurrent Hepatocellular Carcinoma Secondary to Hepatitis C Virus following Liver Transplantation.MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?The Expression Pattern of MicroRNAs and the Associated Pathways Involved in the Development of Porcine Placental Folds That Contribute to the Expansion of the Exchange Surface Area.Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells.Regulation of signal transduction by glutathione transferases.PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma.Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.Identification of early indicators of altered metabolism in normal development using a rodent model system.Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells.IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer.Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma.Research Advances in the Correlation between Peroxisome Proliferator-Activated Receptor-γ and Digestive Cancers.gene function during hepatoma cells proliferationTroglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3
P2860
Q26750845-347C633E-74C8-4A59-A1AE-DE95CA73EDD6Q26778328-33C74E0A-8B0B-4635-BC00-4BDBC7ED5C0BQ27002540-72364AE9-86FF-4274-904E-B958181183B9Q27011352-CF05AB8D-8BDD-42BE-835A-D764765B1F43Q33827192-1C01A865-0A70-4B3B-B63D-35B2F4E1C3F8Q34685429-6482A0B6-C6E0-4B3E-9CC3-16D7D0DED8CBQ34983695-8E5A91AD-0DC8-42EB-AD7B-B210B2EA57FBQ35194042-44DC9036-075A-4CD2-9518-B1AE13A53610Q35666432-CF761F11-97DB-4E7B-B9E9-3DE7525B3087Q36595097-18CF6045-4C34-4AC8-AE68-4E1AC037605CQ37031730-1E11B720-0BB6-42F3-AB6A-F225FD941CA5Q37059954-BB3D6414-10C5-40BF-AFD8-DD5A4896B2C4Q37209921-94CEA4E0-CCDB-45DC-BBDA-828A84E8FFA9Q37575571-52E52CF0-7A25-42D5-9C47-14999940C2CDQ37682244-C910215B-E622-4C67-A644-D863C382556EQ37691021-9EB2907A-82A3-433D-9A95-7F97E7D23662Q38097984-D93ED2DB-649D-4687-B661-383AA97F5660Q38443653-F4E7A7A1-38F9-463C-8B34-579BDA32E1A4Q38661239-3D53AE13-F7C2-4237-B2DD-F2209188E899Q38828335-24C57CF0-2EA0-4C83-BECB-9011A134B1BCQ39043081-A212E8B4-14E3-4293-9D38-1EF8688E4A4DQ39156798-4A54639E-1207-4DFB-9BBC-A3A4DD78B5E6Q39282922-ACD43B6E-5DBA-4AC9-851D-F4BBF09BD1BAQ40254590-D2A64FC9-57A1-488C-923E-30F6B8FBEE46Q40707324-40C1BB3D-A2F1-4BB7-A540-39AA6CCAC7A5Q40756070-48B8E5A8-7C9C-4574-B71D-325A01980803Q41880464-10421C54-CE56-46B1-B536-E8CC3E0B3925Q41901021-C0E9B33F-74FC-40E8-B0F2-4A3E89D92CE1Q42125206-D1E32545-8012-4109-A478-864EA4AC592FQ43778009-57AA1C4A-B9F8-4428-99C3-485D96CD41F4Q47144193-271AA559-4B33-4CC3-8F3B-4999A1E38ECEQ50056326-0E539ED2-CC22-47A1-8D9C-A38516B9FCD0Q51620910-CDED0838-4FDD-4569-9DE7-E2EF1AC2994DQ51706809-8F7DEB8B-1D58-4D39-8974-E3D60B969D6BQ52564728-EEBD3904-15CD-4165-A4AB-1BFB5061882BQ53089247-E733320E-C5A3-4599-9D8C-7A0D8D122355Q53218066-0E944510-3B81-4650-9570-0833AC0D778BQ55361330-D2FD33E3-002B-4897-A2FF-DB3B2646837BQ58697722-8480F336-DF31-423B-B961-49F5A58C104AQ58794883-93C361B8-C011-43B7-97BA-F2725BC40782
P2860
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
@ast
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
@en
type
label
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
@ast
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
@en
prefLabel
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
@ast
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
@en
P2093
P2860
P356
P1476
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
@en
P2093
G C Farrell
J T Y Cheng
P2860
P2888
P304
P356
10.1038/BJC.2012.130
P407
P577
2012-04-01T00:00:00Z